Document is current
Any future updates will be listed below
-
Authors
Stenlander, Caroline
Lindahl, Hannes
Wahren-Borgström, Emelie
Geier, Christoph B.
Sediva, Anna
Fevang, Børre
Milito, Cinzia
Varandas, Cláudia
Roca-Oporto, Cristina
Pulvirenti, Federica
Hodl, Isabel
Malkusova, Ivana
Rivière, Jacques G.
Litzman, Jiri
Walter, Jolan E.
Hanitsch, Leif G.
Neth, Olaf
Kralickova, Pavlina
Miller, Rahim
Shaffren, Serena
Silva, Susana L.
Katzenstein, Terese
Martelius, Timi
Steiner, Urs C.
Smith, C. I. Edvard
Warnatz, Klaus
Bergman, Peter
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 30 March 2025
Accepted: 27 October 2025
First Online: 15 November 2025
Declarations
:
: Conflict of interest statementTimi Martelius reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from CSL Behring, support for attending meetings and/or travel from CSL Behring and Takeda. He is a member of the Finnish National immunization technical advisory group (NITAG).Anna Sediva reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Octapharma and Takeda.Börre Fevang reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Takeda.Isabel Hodl reports support for attending meetings and/or travel from CSL BehringJiri Litzman reports support for attending meetings and/or travel from CSL BehringTerese L Katzenstein has received grants or contracts from Gilead, consulting fees from Gilead, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Takeda, Vertex, CLS Behring, support for attending meetings and/or travel from Vertex, Takeda and Viatris, She is a member of guidelines group under the auspices of the Danish Society for Infectious Diseases regarding spondylodiscitis, fertility therapy for individuals living with HIV and/or hepatitis and for post-exposure prophylaxis after possible HIV exposure.Klaus Warnatz reports grants or contracts from Takeda, consulting fees from Grifols and LFB Biomedicaments, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from CSL Behring and Takeda.Peter Bergman reports honoraria for educational events from CSL Behring.No other author has any conflict of interest to declare.
